FDA Grants Breakthrough Therapy Designation for Xolair (Omalizumab) for Food Allergies By: Genentech News Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Xolair® (omalizumab) for the prevention of severe allergic reactions [..]
FDA Approved First siRNA Based New Class of Drug for a Rare Genetic Disease By: Alnylam News Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the United States Food and Drug Administration (FDA) approved ONPATTRO™ (patisiran) lipid complex injection, a first-of-its-kind RNA interference (RNAi) therapeutic, for the treatment [..]
WBF NYC 2018 – Nov. 14-15 | NY’s Top Innovation Conference What is the World Business Forum [..]
These On-chip Optical Filter Can Processes Wide Range of Light Wavelengths By: Rob Matheson’ | MIT News Office MIT researchers have designed an optical filter on a chip that can process optical signals from across an extremely wide spectrum of light at once, something never before available to integrated optics [..]
New Era for Migraine Patients: EU Approved Aimovig® of Novartis Novartis announced that the European Commission (EC) approved Aimovig® (erenumab) for the prevention of migraine in adults experiencing four or more migraine days per month. Aimovig is the first and only treatment specifically designed for migraine prevention to be approved [..]
EPIDIOLEX®:First FDA-approved Drug Derived From Marijuana GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that the U.S. Food and Drug Administration [..]
FDA Approves TPOXX® :The First Drug For Smallpox SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Food and Drug Administration (FDA) has approved oral TPOXX® (tecovirimat) for the treatment of smallpox to mitigate the impact of a potential outbreak. TPOXX, a small-molecule [..]
World’s first Gesture based workflow automation device, The KAI launches on Indegogo this May Bangalore, India, May 22, 2018 KAI launches on the crowd funding site Indegogo. Starting from $129 for early bird special. The KAI is a gesture based wearable controller that enhances intuitive digital interaction. The Kai harnesses [..]
Let it rain! New coatings make natural fabrics waterproof MIT-developed process could offer nontoxic alternative to environmentally harmful chemicals. By: David L. Chandler | MIT News Office Fabrics that resist water are essential for everything from rainwear to military tents, but conventional water-repellent coatings have been shown to persist in [..]
This Wireless System Can Power Devices Inside the Body By: Anne Trafton | MIT News Office MIT researchers, working with scientists from Brigham and Women’s Hospital, have developed a new way to power and communicate with devices implanted deep within the human body. Such devices could be used to deliver [..]
Novartis’s Gilenya® got Approved by FDA for Pediatric Relapsing Multiple Sclerosis By: Novartis News Novartis announced that the US Food and Drug Administration (FDA) has approved Gilenya® (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis (RMS), making [..]
FDA Grants Priority Review to Genentech’s Cancer Immunotherapy Tecentriq By: Genentech News Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab), in combination [..]
First-in-World Robot-Assisted Spinal Surgery By: University of Pennsylvania School of Medicine Noah Pernikoff is back to his life in New York City after becoming the first patient in the world to undergo a complex three-part, robotic-assisted surgery. The robotic arms made it possible for the multidisciplinary team at Penn to successfully [..]
Could Robots be Counsellors? Early Research Shows Positive User Experience By: University of Plymouth News New research has shown for the first time that a social robot can deliver a ‘helpful’ and ‘enjoyable’ motivational interview (MI) – a counselling technique designed to support behaviour change. Many participants in the University of [..]
Tafinlar® + Mekinist® of Novartis Receives FDA Approval for the Treatment of BRAF V600-Mutant Melanoma By: Novartis News Novartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations, as [..]
Novartis Receives Second FDA Approval for Kymriah® to Treat B-cell Lymphoma By: Novartis News Novartis today announced the US Food and Drug Administration (FDA) has approved Kymriah® (tisagenlecleucel) suspension for intravenous infusion for its second indication – the treatment of adult patients with relapsed or refractory (r/r) large B-cell lymphoma after two [..]
First Revolutionary Contact Lens Innovation of J&J Received Clearance From US-FDA By: Johnson & Johnson News Johnson & Johnson Vision today announced ACUVUE OASYS® with Transitions® Light Intelligent Technology™ first of its kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the [..]
FDA Permits Marketing of Artificial Intelligence-Based IDx-DR for Detection of Diabetic Retinopathy By: FDA News The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic [..]
Breakthrough Made in Atomically Thin Magnets By: Syl Kacapyr | Cornell News Cornell researchers have become the first to control atomically thin magnets with an electric field, a breakthrough that provides a blueprint for producing exceptionally powerful and efficient data storage in computer chips, among other applications. The research is detailed [..]
New Test Kit for Personalized, Precise Cancer Therapy A team of scientists led by Professor Lim Chwee Teck, Principal Investigator at the Mechanobiology Institute, Singapore (MBI) and the Department of Biomedical Engineering at the National University of Singapore (NUS) and NUS PhD graduate Dr Khoo Bee Luan, has developed [..]
Novel Chip for Fast and Accurate Disease Detection at Low Cost By: NYU News A novel invention by a team of researchers from the National University of Singapore (NUS) holds promise for a faster and cheaper way to diagnose diseases with high accuracy. Professor Zhang Yong from the Department of [..]
Greener and Cheaper Technique for Biofuel Production By: NYU News A team of engineers from the National University of Singapore (NUS) recently discovered that a naturally occurring bacterium, Thermoanaerobacterium thermosaccharolyticum TG57, isolated from waste generated after harvesting mushrooms, is capable of directly converting cellulose, a plant-based material, to biobutanol. A research team [..]
New insight about how viruses use host proteins to their advantage By: Uppsala University Viruses have a very limited set of genes and therefore must use the cellular machineries of their hosts for most parts of their growth. A new study, led by scientists at Uppsala University, has discovered a specific [..]
Even DNA that Doesn’t Encode Genes Can Drive Cancer By: UCSD News Most of the human genome — 98 percent — is made up of DNA but doesn’t actually encode genes, the recipes cells use to build proteins. The vast majority of genetic mutations associated with cancer occur in these [..]
MIT Engineers Turn Plastic Insulator into Heat Conductor By: Jennifer Chu | MIT News Office Plastics are excellent insulators, meaning they can efficiently trap heat — a quality that can be an advantage in something like a coffee cup sleeve. But this insulating property is less desirable in products such [..]
Google lost Android Battle With Oracle, Could Owe Oracle $ 8.8 Billions As reported by CNN Money An appeals court said on Tuesday that Google violated copyright laws when it used Oracle’s open-source Java software to build the Android platform in 2009. Tuesday’s ruling is the latest development in a [..]
Paper-Folding Art Inspires Better Bandages By: Jennifer Chu | MIT News Office Scraped up knees and elbows are tricky places to securely apply a bandage. More often than not, the adhesive will peel away from the skin with just a few bends of the affected joint. Now MIT engineers have [..]
Novartis drug Tasigna® approved by FDA to treat children with rare form of leukemia By: Novartis News Novartis announced today that the US Food and Drug Administration (FDA) expanded the indication for Tasigna® (nilotinib) to include treatment of first- and second-line pediatric patients one year of age or older with Philadelphia [..]
FDA Approves Genentech’s Lucentis® Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved the Lucentis® (ranibizumab injection) 0.3 mg prefilled syringe (PFS) as a new method of administering [..]
Novartis teams up with Harvard to develop next-generation biomaterial systems to deliver immunotherapies By: Novartis News Novartis announced today that it is teaming up with scientists from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Cancer Institute to develop biomaterial systems for its portfolio of [..]
Copyright © 2024 | WordPress Theme by MH Themes